Atovaquone and Proguanil Hydrochloride Tablets 100 mg

Atovaquone and Proguanil Hydrochloride Tablets 100 mg are a combination medication used for malaria prevention and treatment. This oral tablet is manufactured by Glenmark Pharmaceuticals Canada Inc.

Atovaquone and Proguanil Hydrochloride Tablets 100 mg are primarily used for the prevention and treatment of malaria, a mosquito-borne disease caused by parasites. This medication is often prescribed for travelers to areas where malaria is common. It works by interfering with the growth of parasites in the red blood cells. People often search for 'what is Atovaquone and Proguanil Hydrochloride used for' when looking for information on malaria prophylaxis.

Common effects of Atovaquone and Proguanil Hydrochloride Tablets 100 mg may include nausea, vomiting, diarrhea, and headache. Some users might experience abdominal pain or loss of appetite. These effects vary from person to person and are not experienced by everyone who takes the medication.

It is important to follow the prescribed dosage and complete the full course of treatment. This medication should be taken with food or a milky drink to enhance absorption. Patients with severe kidney disease or certain metabolic disorders should consult their healthcare provider before use. Always store the tablets in a cool, dry place away from direct sunlight.

Atovaquone and Proguanil Hydrochloride Tablets 100 mg may interact with other medications, including certain antibiotics, antifungals, and anticonvulsants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided as it may exacerbate side effects.